SHAREHOLDER ALERT: Weiss Law Reminds TMX, FMTX, IEA, and VIVO Shareholders About Its Ongoing Investigations

NEW YORK, Oct. 4, 2022 /PRNewswire/ --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Terminix Global Holdings, Inc. (NYSE: TMX), in connection with the proposed acquisition of TMX by Rentokil Initial plc ("Rentokil Initial"). Pursuant to the merger agreement, TMX shareholders will receive approximately 643.29 million new Rentokil Initial shares (representing approximately 128.66 million American depository shares ("ADSs"), based on a 1:5 ADS to Rentokil Initial share ratio) and approximately $1.3 billion in cash. If you own TMX shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/tmx 

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX), in connection with the proposed acquisition of FMTX by Novo Nordisk A/S via tender offer. Under the terms of the merger agreement, FMTX shareholders will receive $20.00 in cash for each share of FMTX common stock owned. If you own FMTX shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/fmtx

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA), in connection with the proposed acquisition of IEA by MasTec, Inc. ("MasTec"). Under the terms of the merger agreement, IEA shareholders will receive $14.00 per share in cash and 0.0483 shares of MasTec common stock for each IEA share owned, representing implied per-share merger consideration of approximately $17.23 based upon MasTec's October 3, 2022 closing price of $66.89. If you own IEA shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/iea

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Meridian Bioscience, Inc. (NASDAQ: VIVO), in connection with the proposed acquisition of VIVO by SD Biosensor, Inc. ("SDB") and SJL Partners LLC ("SJL"). Under the merger agreement, VIVO shareholders will receive $34.00 in cash for each share of VIVO stock owned, leaving SDB owning approximately 60% and SJL owning approximately 40% of Meridian. If you own VIVO shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/vivo

SOURCE Weiss Law

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED